1 completed, 1 suspended. 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Suspended 1 |
Follow Eusol Biotech Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect and Safety of Recombinant Fibroblast Growth Factor-1 for Carpal Tunnel Syndrome Sono-guided injection with ES135, Sono-guided injection with placebo - Carpal Tunnel Syndrome | Not applicable | Completed | Tri-Service General Hospital (TSGH) | 24 | 2024-03-22 | 2025-09-10 |
| A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Safety and Efficacy of ES135 in Subjects With Spinal Cord Injury ES135 - Spinal Cord Injuries | Phase 3 | Suspended | Eusol Biotech Co., Ltd. | 160 | 2018-03-07 | 2024-05-08 |
Carpal Tunnel Syndrome (1) · Spinal Cord Injuries (1)
Taiwan (2)
Yu Chi Su, MD (1) · Yung-Tsan Wu, MD (1)